Loading...
XNAS
ACHV
Market cap743mUSD
Oct 08, Last price  
7.19USD
1D
-0.69%
1Q
17.68%
Jan 2017
-99.35%
Name

Achieve Life Sciences Inc

Chart & performance

D1W1MN
XNAS:ACHV chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
74.18%
Rev. gr., 5y
%
Revenues
0
22,391,85820,130,66320,131,00025,539,00013,616,0005,496,00020,095,00029,882,00027,116,00018,160,0005,062,000000000000
Net income
-55m
L+37.21%
-23,551,296-13,063,168-4,204,0005,476,000-12,584,000-14,673,000-21,098,000-31,849,000-26,240,000-16,801,000-20,129,000-10,583,000-12,687,000-16,395,000-14,661,000-33,152,000-42,350,000-29,815,000-39,827,000-54,648,000
CFO
-49m
L+66.16%
-19,680,553-23,335,332-12,307,00034,878,000-26,840,000-20,263,000-43,493,000-35,927,000-17,308,000-9,101,000-29,683,000-9,107,000-10,623,000-15,216,000-13,474,000-29,440,000-37,569,000-24,479,000-29,770,000-49,465,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.

Key people

Richard Stewart
Chairman of the Board, Chief Executive Officer · since 2017
John A. Bencich
Chief Financial Officer, Chief Operating Officer, Executive Vice President · since 2017
Cindy Jacobs
Executive Vice President, Chief Medical Officer · since 2008
Anthony Clarke
President, Chief Scientific Officer, Director · since 2017
Scott Daniel Cormack
Independent Director · since 2017
Donald Joseph
Independent Director · since 2017
Martin A. Mattingly
Independent Director · since 2010
Jay Moyes
Independent Director · since 2017
H. Stewart Parker
Independent Director · since 2010
URL
http://achievelifesciences.com/
IPO date
Oct 12, 1995
Employees
20
Domiciled in
US
Incorporated in
US
Legal address
c/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
22722 29th Drive Southeast; Suite 100
Bothell, WA 98021
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT